Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BETH A BILSKI

Allopathic & Osteopathic Physicians Family Medicine

NPI
1750328076
CMS profile
79640
Location
NEWARK, DE

General Payments · PY2018–2024

$2,988.16

  • Reported across 107 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$522.99

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $522.99 15

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $293.57 18
PY2019 $817.79 17
PY2020 $315.54 15
PY2021 $347.47 19
PY2022 $318.66 13
PY2023 $372.14 10
PY2024 $522.99 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $79.78 03/14/2024 Food and Beverage Undisputed 01/23/2026 1125238285 CMS
Abbott Laboratories $18.19 11/11/2024 Food and Beverage Undisputed 01/23/2026 1125238289 CMS
ABBVIE INC. $22.83 04/17/2024 Food and Beverage Undisputed 01/23/2026 1103328052 CMS
Astellas Pharma US Inc $15.56 03/20/2024 Food and Beverage Undisputed 01/23/2026 1139304586 CMS
AstraZeneca Pharmaceuticals LP $67.02 01/22/2024 Food and Beverage Undisputed 01/23/2026 1104584440 CMS
AstraZeneca Pharmaceuticals LP $14.71 04/29/2024 Food and Beverage Undisputed 01/23/2026 1104533042 CMS
AstraZeneca Pharmaceuticals LP $24.03 07/09/2024 Food and Beverage Undisputed 01/23/2026 1104679419 CMS
AstraZeneca Pharmaceuticals LP $25.44 12/11/2024 Food and Beverage Undisputed 01/23/2026 1105606007 CMS
Axsome Therapeutics, Inc. $86.13 12/11/2024 Food and Beverage Undisputed 01/23/2026 1148267421 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $79.13 06/20/2024 Food and Beverage Undisputed 01/23/2026 1118138204 CMS
GlaxoSmithKline, LLC. $16.64 06/03/2024 Food and Beverage Undisputed 01/23/2026 1116424077 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.48 11/18/2024 Food and Beverage Undisputed 01/23/2026 1143195096 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.23 12/17/2024 Food and Beverage Undisputed 01/23/2026 1143195099 CMS
Lilly USA, LLC $13.95 10/07/2024 Food and Beverage Undisputed 01/23/2026 1136013173 CMS
Xeris Pharmaceuticals, Inc. $16.87 09/17/2024 Food and Beverage Undisputed 01/23/2026 1144588604 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.